Halil Beydilli

Halil Beydilli

Auto-generated profile, based on publicly available information

Halil Beydilli

Department of Emergency, Mugla Sıtkı Koçman University, Faculty of Medicine, Mugla, Turkey

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 2015 in Experimental and Therapeutic Medicine
Verified
Journal Article
Open access
PDF file
SKSerdar Kalemci
Serdar Kalemci
YTYaşar Topal
Yaşar Topal
SÇSerkan Yaşar Çelik
Serkan Yaşar Çelik
NYNigar Yilmaz
Nigar Yilmaz
HBHalil Beydilli
Halil Beydilli
IAIrfan Altuntas
Irfan Altuntas
The aim of the present study was to assess the protective effect of silibinin against methotrexate (MTX)-induced pulmonary toxicity. Rats were divided into four groups (MTX, MTX + silibinin, silibinin and control. MTX was injected intraperitoneally (i.p) into female Wistar rats (10 mg/kg/day for 3 days), which resulted in significant increases in the serum levels of alanine aminotransferase, aspartate aminotransferase and oxidant enzymes, including nitric oxide and myeloperoxidase. Furthermore, significant reductions were detected in the serum activity levels of the antioxidative enzymes, glutathione peroxidase and superoxide dismutase, when compared with the control group. However, administration of silibinin (100 mg/kg/day for 10 days, i.p.) was shown to ameliorate the MTX-induced pulmonary toxicity, as indicated by the normalization of the oxidative stress parameters. Furthermore, silibinin treatment was demonstrated to reduce the histopathological changes associated with MTX. In conclusion, silibinin exhibited protective effects against MTX-induced pulmonary toxicity, which may be attributed to its antioxidant activity.

23 June 2015 in Case Reports in Emergency Medicine
Verified
Journal Article
Open access
PDF file
BYBirdal Yildirim
Birdal Yildirim
UKUlku Karagoz
Ulku Karagoz
EAEthem Acar
Ethem Acar
HBHalil Beydilli
Halil Beydilli
EYEmine Nese Yeniceri
Emine Nese Yeniceri
ŞKŞükrü Kasap
Şükrü Kasap
Prilocaine-induced methemoglobinemia is a rarely seen condition. In this paper, a case is presented with methemoglobinemia developed secondary to prilocaine use in a liposuction procedure, and the importance of this rarely seen condition is emphasized. A 20-year-old female patient presented with complaints of prostration, lassitude, shivering, shortness of breath, and cyanosis. It was learned that the patient underwent nearly 1000mg prilocaine infiltration 8 hours priorly during a liposuction procedure. At admission, her blood pressure (130/80mmHg), pulse rate (140bpm), body temperature (36°C), and respiratory rate (40/min) were recorded. The patient had marked acrocyanosis. The arterial blood gas methemoglobin level was measured as 40%. The patient received oxygen therapy with a mask and was administered vitamin C in normal saline (500mg tid), N-acetylcysteine (300mg tid), and 50mg 10% methylene blue in the intensive care unit of the internal medicine department. Methemoglobin level dropped down to 2% after her treatment with methylene blue and she was clinically cured and discharged 2 days later. Emergency service physicians should remember to consider methemoglobinemia when making a differential diagnosis between dyspnea and cyanosis developing after prilocaine infiltration performed for liposuctions in the adult age group.

8 June 2016 in Journal of Clinical Orthopaedics and Trauma
Verified
Journal Article
Closed access
PDF file
ÖYÖnder Yeniçeri
Önder Yeniçeri
NCNesat Cullu
Nesat Cullu
HBHalil Beydilli
Halil Beydilli
MDMehmet Deveer
Mehmet Deveer
RKRabia Mihriban Kilinc
Rabia Mihriban Kilinc

24 October 2014 in BMJ Case Reports
Verified
Journal Article
Open access
IAIbrahim Altun
Ibrahim Altun
FAFatih Akin
Fatih Akin
CSCem Sahin
Cem Sahin
HBHalil Beydilli
Halil Beydilli
Arrhythmogenic right ventricular dysplasia (ARVD) is a progressive condition with the right ventricular myocardium being replaced by fibrofatty tissue. It is a hereditary disorder mostly caused by desmosome gene mutations. The prevalence of arrhythmogenic right ventricular cardiomyopathy is about 1/1000–5000. Clinical presentation is usually related to ventricular tachycardias, syncope, presyncope or ventricular fibrillation leading to cardiac arrest, mostly in young people and athletes. We report a case of a 17-year-old boy from Turkey, who was referred to our cardiology department for an ECG, required of him prior to joining a football team.